These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6585468)

  • 21. Effect of combination therapy with cimetidine and pirenzepine on plasma parathyroid hormone and calcitonin levels in hemodialyzed patients.
    Minar E; Zazgornik J; Dudczak R; Marosi L
    Klin Wochenschr; 1984 Jun; 62(11):549-53. PubMed ID: 6547988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parathyroid hormone plasma level in untreated chronic renal failure and in hemodialyzed patients.
    Fuss M; De Backer M; Brauman J; Nijs-Dewolf N; Manderlier T; Brauman H; Corvilain J
    Nephron; 1976; 17(2):144-54. PubMed ID: 940620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concurrent hyperthyroidism and hyperparathyroidism: influence of hyperthyroidism on serum magnesium, free calcium and parathyroid hormone.
    Lam HC; Ho LT; Tang KT; Ching KN
    Taiwan Yi Xue Hui Za Zhi; 1989 Jun; 88(6):601-5. PubMed ID: 2794961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between serum magnesium and risk factors of cardiovascular disease in hemodialysis patients.
    Khatami MR; Mirchi E; Khazaeipour Z; Abdollahi A; Jahanmardi A
    Iran J Kidney Dis; 2013 Jan; 7(1):47-52. PubMed ID: 23314142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hyperparathyroidism in hemodialysis patients: studies on parathyroid regulation and classification problems (author's transl)].
    Augustin R; Hackeng WH
    Klin Wochenschr; 1981 Nov; 59(22):1251-9. PubMed ID: 7311395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between magnesium and secondary hyperparathyroidism during long-term hemodialysis.
    Pletka P; Bernstein DS; Hampers CL; Merrill JP; Sherwood LM
    Metabolism; 1974 Jul; 23(7):619-30. PubMed ID: 4600477
    [No Abstract]   [Full Text] [Related]  

  • 27. Secondary hyperparathyroidism in patients on maintenance hemodialysis: study of the N and C-terminal parathyroid hormones.
    Hida M; Shimbo T; Nakamura K; Wakabayashi T; Saitoh H; Satoh T
    Tokai J Exp Clin Med; 1983 Jul; 8(3):225-8. PubMed ID: 6670108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperparathyroidism, glucose tolerance and platelet intracellular free calcium in chronic renal failure.
    Lu KC; Shieh SD; Lin SH; Chyr SH; Lin YF; Diang LK; Li BL; Sheu WH; Ding YA
    Q J Med; 1994 Jun; 87(6):359-65. PubMed ID: 8041868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis.
    Block GA; Martin KJ; de Francisco AL; Turner SA; Avram MM; Suranyi MG; Hercz G; Cunningham J; Abu-Alfa AK; Messa P; Coyne DW; Locatelli F; Cohen RM; Evenepoel P; Moe SM; Fournier A; Braun J; McCary LC; Zani VJ; Olson KA; Drüeke TB; Goodman WG
    N Engl J Med; 2004 Apr; 350(15):1516-25. PubMed ID: 15071126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Radioimmunologic determination of circulating parathyroid hormone in patients with primary and secondary hyperparathyroidism].
    Lo Giudice C; Cascone C; Manente P; Gasparoni P; De Luca M; Rota G; Conte N
    Minerva Med; 1982 Dec; 73(48):3425-8. PubMed ID: 7177469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between serum parathyroid hormone and trace elements (serum zinc and magnesium) in hemodialyzed chronic renal failure children.
    El Tayeb AA; Abd El-Mottaleb NA; Abdel Aziz EA
    Biol Trace Elem Res; 2009 May; 128(2):128-34. PubMed ID: 18972069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of serum magnesium with serum parathormone levels in patients on regular hemodialysis.
    Baradaran A; Nasri H
    Saudi J Kidney Dis Transpl; 2006 Sep; 17(3):344-50. PubMed ID: 16970254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H; Baradaran A
    J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of dialysate calcium concentration on plasma parathyroid hormone during hemodialysis.
    McIntosh CH; Fuchs C; Dorn D; Quellhorst E; Henning HV; Hesch RD; Scheler F
    Nephron; 1977; 19(2):88-94. PubMed ID: 887190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Magnesium, calcium and PTH relationships in dialysis patients after magnesium repletion.
    Kenny MA; Casillas E; Ahmad S
    Nephron; 1987; 46(2):199-205. PubMed ID: 3600928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abnormal mineral metabolism and mortality in hemodialysis patients with secondary hyperparathyroidism: evidence from marginal structural models used to adjust for time-dependent confounding.
    Fukagawa M; Kido R; Komaba H; Onishi Y; Yamaguchi T; Hasegawa T; Kurita N; Fukuma S; Akizawa T; Fukuhara S
    Am J Kidney Dis; 2014 Jun; 63(6):979-87. PubMed ID: 24119541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Economic analysis of cinacalcet in combination with low-dose vitamin D versus flexible-dose vitamin D in treating secondary hyperparathyroidism in hemodialysis patients.
    Shireman TI; Almehmi A; Wetmore JB; Lu J; Pregenzer M; Quarles LD
    Am J Kidney Dis; 2010 Dec; 56(6):1108-16. PubMed ID: 20951487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of cimetidine on parathyroid hormone in chronic uremia.
    Bourgoignie JJ; Jacob AI; Gavellas G; Canterbury J
    Adv Exp Med Biol; 1980; 128():505-14. PubMed ID: 7191619
    [No Abstract]   [Full Text] [Related]  

  • 39. Low doses of calcitriol or calcium carbonate for the prevention of hyperparathyroidism in predialysis patients?
    Fournier A; Oprisiu R; Moriniere P; El Esper N
    Nephrol Dial Transplant; 1996 Jul; 11(7):1493-5. PubMed ID: 8815432
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of calcium-channel blockers on calcium-phosphate metabolism in patients with end-stage renal disease.
    Lippuner K; Zehnder HJ; Casez JP; Takkinen R; Descoeudres C; Jaeger P
    Nephrol Dial Transplant; 1996 Jan; 11(1):70-4. PubMed ID: 8649655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.